BRINGING YOU INFORMATION.  PROVIDING YOU A PLATFORM.

 

 
THE PHARMA REVIEW (JULY - AUGUST 2013)

Knowledge, Attitude and Perception of Physicians Towards ADR Reporting-Results of Pilot Study

Rakesh Kumar Rishi1, Dr. Rakesh K. Patel2 & Prof. Anil Bhandari3

Introduction: The drug-related harm is currently one of the most important public health problems all over the world, although public and scientific attention has already focused on adverse drug reactions (ADRs) since the thalidomide disaster in the early 1960s1-3. ADRs are more common than might be expected and there can never be a guarantee that a medicine is completely safe. The current approach to postmarketing surveillance mainly relies on spontaneous reporting4. This method is being utilized by many drug regulatory authorities worldwide. If ADRs that are not detected during clinical trials are to be known, investigated and communicated, and the appropriate action taken, then it is crucial that post-marketing pharmacovigilance of all medicines is comprehensive. After closure of earlier “National Pharmacovigilance Programme”, which was funded by World Bank, India has recently launched a new programme – “Pharmacovigilance Programme of India (PVPI)”. Aim of the present pilot study was to explore the awareness of “Pharmacovigilance Programme of India (PVPI)” of CDSCO, Ministry of Health, Govt. of India among physicians in the country. Some of the parameters were also investigated in this study to understand key issues involved with ADR reporting. 

 

Go to Content Index Page

PHARMA REVIEW - ARTICLES ARCHIVE ( COMPLETE LIST)

 

The above content is an abstract only. For the full Article please contact:
KONGPOSH Publications Pvt. Ltd.
ICS House, C-19, Commercial Complex, SDA, Opp. IIT Gate, New Delhi, India -110016
Tel.: 26855839, 9811195411
Email: kongposhpub@gmail.com, Website: http://www.kppub.com

 
 
 
 

Copyright © KONGPOSH PUBLICATIONS Pvt. Ltd.